Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Appl Ergon ; 96: 103477, 2021 Oct.
Article in English | MEDLINE | ID: mdl-34107433

ABSTRACT

Video game training can effectively improve the cognition of older adults. However, whether video game types and game devices influence the training effects of video games remains controversial. This meta-analysis aimed to access and evaluate the effects of video game types and game devices in video game training on the cognition of older adults. Interestingly, results indicated that mouse/keyboard was superior over other video game devices on perceptual-motor function. The effect size (Hedge's g) for perceptual-motor function decreased by 1.777 and 1.722 when the video game training device changed from mouse/keyboard to driving simulator and motion controller. The effects of cognitive training game and conventional video game were moderated by session length. More well-designed studies are required to clarify the unique efficacy of video game types and devices for older adults with video game training.


Subject(s)
Video Games , Aged , Cognition , Humans
2.
J Pediatr Endocrinol Metab ; 32(10): 1071-1075, 2019 Oct 25.
Article in English | MEDLINE | ID: mdl-31415238

ABSTRACT

Objective This study was done to evaluate the emotional and behavioral status of precocious puberty patients and analyze the effect of gonadotropin-releasing hormone agonist (GnRHa) treatment. Methods Sixty-six female precocious puberty patients were enrolled prospectively for the study at Kangdong Sacred Heart Hospital of Hallym University Medical Center from September 2011 to December 2012 and self-administered questionnaire was completed during the GnRHa treatment initiation period and after 12 months from the first injection. The patients were evaluated using the Korean version of Child Behavior Checklist (K-CBCL) and Children's Depression Inventory (CDI). Results A total of 30.3% (n = 20) of the patients scored within the clinical range for one or more scales of K-CBCL at the initiation of GnRHa treatment, but only 10.6% (seven patients) were within the clinical range after 1 year of treatment. Average CDI scores of the patients decreased from baseline 6.5 ± 6.0 to 4.9 ± 4.7 after GnRHa therapy. Conclusions This study shows that both K-CBCL and CDI scores improved from baseline score ranges after 1 year of GnRHa treatment in female central precocious puberty patients while significant psychological problems of clinical range amongst them were not noted.


Subject(s)
Depression/epidemiology , Gonadotropin-Releasing Hormone/agonists , Leuprolide/administration & dosage , Puberty, Precocious/drug therapy , Stress, Psychological/epidemiology , Child , Depression/chemically induced , Female , Fertility Agents, Female/administration & dosage , Fertility Agents, Female/adverse effects , Humans , Incidence , Leuprolide/adverse effects , Prognosis , Prospective Studies , Puberty, Precocious/pathology , Puberty, Precocious/psychology , Republic of Korea/epidemiology , Stress, Psychological/chemically induced , Surveys and Questionnaires
3.
Epilepsia ; 59(12): 2249-2259, 2018 12.
Article in English | MEDLINE | ID: mdl-30370541

ABSTRACT

OBJECTIVE: With the recognition of epilepsy as a network disease that disrupts the organizing ability of resting-state brain networks, vagus nerve stimulation (VNS) may control epileptic seizures through modulation of functional connectivity. We evaluated preoperative 2-deoxy-2[18 F]fluoro-D-glucose (FDG) positron emission tomography (PET) in VNS-implanted pediatric patients with refractory epilepsy to analyze the metabolic connectivity of patients and its prognostic role in seizure control. METHODS: Preoperative PET data of 66 VNS pediatric patients who were followed up for a minimum of 1 year after the procedure were collected for the study. Retrospective review of the patients' charts was performed, and five patients with inappropriate PET data or major health issues were excluded. We conducted an independent component analysis of FDG-PET to extract spatial metabolic components and their activities, which were used to perform cross-sectional metabolic network analysis. We divided the patients into VNS-effective and VNS-ineffective groups (VNS-effective group, ≥50% seizure reduction; VNS-ineffective group, <50% reduction) and compared metabolic connectivity differences between groups using a permutation test. RESULTS: Thirty-four (55.7%) patients showed >50% seizure reduction from baseline frequency 1 year after VNS. A significant difference in metabolic connectivity evaluated by preoperative FDG-PET was noted between groups. Relative changes in glucose metabolism were strongly connected among the areas of brainstem, cingulate gyrus, cerebellum, bilateral insula, and putamen in patients with <50% seizure control after VNS. SIGNIFICANCE: This study shows that seizure outcome of VNS may be influenced by metabolic connectivity, which can be obtained from preoperative PET imaging. This study of metabolic connectivity analysis may contribute in further understanding of the mechanism of VNS in intractable seizures.


Subject(s)
Drug Resistant Epilepsy/diagnostic imaging , Drug Resistant Epilepsy/therapy , Vagus Nerve Stimulation , Adolescent , Adult , Brain Chemistry , Child , Cross-Sectional Studies , Drug Resistant Epilepsy/metabolism , Female , Fluorodeoxyglucose F18 , Glucose/metabolism , Humans , Male , Metabolic Networks and Pathways , Positron-Emission Tomography , Prognosis , Radiopharmaceuticals , Retrospective Studies , Seizures/prevention & control , Treatment Outcome , Young Adult
4.
Neurology ; 84(23): 2312-9, 2015 Jun 09.
Article in English | MEDLINE | ID: mdl-25948717

ABSTRACT

OBJECTIVE: To prospectively evaluate the neuropsychological effect of levetiracetam (LVT) in comparison with carbamazepine (CBZ) and its efficacy and tolerability as a monotherapy in children with focal epilepsy. METHODS: A total of 121 out of 135 screened children (4-16 years) were randomly assigned to LVT or CBZ groups in a multicenter, parallel-group, open-label trial. The study's primary endpoints were defined as the end of 52 weeks of treatment, followed by analysis of changes observed in a series of follow-up neurocognitive, behavioral, and emotional function tests performed during treatment in the per protocol population. Drug efficacy and tolerability were also analyzed among the intention-to-treat (ITT) population (ClinicalTrials.gov, number NCT02208492). RESULTS: Eighty-one patients (41 LVT, 40 CBZ) from the randomly assigned ITT population of 121 children (57 LVT, 64 CBZ) were followed up to their last visit. No significant worsening or differences were noted between groups in neuropsychological tests, except for the Children's Depression Inventory (LVT -1.97 vs CBZ +1.43, p = 0.027, [+] improvement of function). LVT-treated patients showed an improvement (p = 0.004) in internalizing behavioral problems on the Korean Child Behavior Checklist. Seizure-free outcomes were not different between the 2 groups (CBZ 57.8% vs LVT 66.7%, p = 0.317). CONCLUSIONS: Neither LVT nor CBZ adversely affected neuropsychological function in pediatric patients. Both medications were considered equally safe and effective as monotherapy in children with focal epilepsy. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that in patients with pediatric focal epilepsy, LVT and CBZ exhibit equivalent effects on neuropsychological function.


Subject(s)
Anticonvulsants/pharmacology , Carbamazepine/pharmacology , Child Behavior/drug effects , Epilepsies, Partial/drug therapy , Intelligence/drug effects , Piracetam/analogs & derivatives , Social Skills , Adolescent , Anticonvulsants/administration & dosage , Anticonvulsants/adverse effects , Carbamazepine/administration & dosage , Carbamazepine/adverse effects , Child , Child, Preschool , Female , Follow-Up Studies , Humans , Levetiracetam , Male , Piracetam/administration & dosage , Piracetam/adverse effects , Piracetam/pharmacology , Treatment Outcome
5.
Brain Dev ; 35(8): 816-20, 2013 Sep.
Article in English | MEDLINE | ID: mdl-23871103

ABSTRACT

PURPOSE: This study sought to evaluate the seizure outcome of infantile spasms (IS) with focal cortical dysplasia (FCD). METHODS: We retrospectively reviewed infantile spasms patients with FCD from 2004 to 2010. We investigated seizure outcome from antiepileptic drug (AED), ketogenic diet (KD), resective surgery, and analyzed the results according to individual imaging studies. RESULTS: Among 404 patients of IS, FCD was confirmed in 51 patients. In retrospective review of brain MRI, only 21 patients (41.2%) were suspected of FCD before 1year of age, but 45 patients (88.2%) became confirmed to FCD by MRI after the age of 1year. Once the spasms were not controlled by 1 or 2 AEDs, the chance of becoming seizure free with additional third or more drugs was very low (2.3%). The seizure free rate was 33.3% (7/21) in patients treated with ketogenic diet, and 73.3% (22/30) in surgical patients, who were both intractable to AEDs. There were no significant differences in seizure free rate in both ketogenic diet and surgical patients, between MRI negative and positive patients prior to 1year of age. CONCLUSIONS: KD and surgery should be considered in medically refractory IS with FCD.


Subject(s)
Malformations of Cortical Development/surgery , Spasms, Infantile/surgery , Child , Child, Preschool , Diagnostic Imaging/methods , Electroencephalography/methods , Female , Follow-Up Studies , Humans , Infant , Magnetic Resonance Imaging/methods , Male , Retrospective Studies , Treatment Outcome
6.
J Paediatr Child Health ; 48(11): 1016-20, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23038991

ABSTRACT

AIMS: We evaluated echocardiography and electrocardiography (ECG) results in children with non-specific mitochondrial disease (MD) in order to study early cardiac involvement, a well-known complication of the disease. METHODS: Among non-specific MD children whose isolated mitochondrial respiratory chain complex I defect was confirmed by muscle biopsy and satisfied the criteria of MD, 27 who had no cardiac symptoms were evaluated by echocardiography and ECG. RESULTS: Three (11.1%) out of the 27 non-specific MD patients had left ventricular ejection fraction of less than 55% and two of them (7.4%) had fractional shortening of less than 26%. ECG abnormalities were observed in 16 of the non-specific MD patients (59.3%). Prolongation of heart rate-corrected QT interval was seen in 11 (40.7%) and widening of the QRS interval in eight (29.6%). Left ventricular ejection fraction and fractional shortening of the patients were significantly decreased compared with those in the control group while heart rate-corrected QT interval was prolonged in the former group. QRS interval was more widened in non-specific MD patients, but without statistical significance. CONCLUSION: The potentially severe cardiac involvement observed in our subjects suggests that early cardiac evaluation after confirming the diagnosis of MD and regular follow-up tests should be strongly recommended in children even in cases without typical cardiac manifestations.


Subject(s)
Electron Transport Complex I , Mitochondrial Diseases/physiopathology , Arrhythmias, Cardiac/diagnostic imaging , Arrhythmias, Cardiac/etiology , Child , Child, Preschool , Early Diagnosis , Echocardiography , Electrocardiography , Electron Transport Complex I/metabolism , Female , Humans , Male , Mitochondrial Diseases/complications , Mitochondrial Diseases/diagnostic imaging , Myocardial Contraction/physiology , Retrospective Studies , Ventricular Dysfunction, Left/diagnostic imaging , Ventricular Dysfunction, Left/etiology
SELECTION OF CITATIONS
SEARCH DETAIL